Related references
Note: Only part of the references are listed.Metformin in Cancer Treatment and Prevention
Daniel R. Morales et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
Metformin and the risk of endometrial cancer: A population-based cohort study
Emily M. Ko et al.
GYNECOLOGIC ONCOLOGY (2015)
Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo
Shintaro Fujihara et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Renata Silva et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The effect of mitochondrial ATP-sensitive potassium channels on apoptosis of chick embryo cecal cells by Eimeria tenella
Sha-sha Yang et al.
RESEARCH IN VETERINARY SCIENCE (2015)
Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway
Zaid H. Maayah et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
Hossam M. Abdallah et al.
JOURNAL OF ADVANCED RESEARCH (2015)
Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
Ting Chen et al.
CANCER BIOLOGY & THERAPY (2015)
Sweat but no gain: Inhibiting proliferation of multidrug resistant cancer cells with ersatzdroges
Yoonseok Kam et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Protective Effects of Calycosin Against CCl4-Induced Liver Injury with Activation of FXR and STAT3 in Mice
Xinli Chen et al.
PHARMACEUTICAL RESEARCH (2015)
Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression
Shu-Ching Hsieh et al.
AMINO ACIDS (2014)
Inhibitory Effect of Valsartan on the Intestinal Absorption and Renal Excretion of Bestatin in Rats
Xiaokui Huo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Mechanisms of P-Glycoprotein Alteration During Anticancer Treatment: Role in the Pharmacokinetic and Pharmacological Effects of Various Substrate Drugs
Takuro Kobori et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner
Ming-Ju Tsai et al.
LUNG CANCER (2014)
Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells
Ming Ming et al.
PLOS ONE (2014)
Metformin and survival in diabetic patients with breast cancer
Sanaa A. El-Benhawy et al.
JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION (2014)
Metformin in cancer prevention and therapy
Jacek Kasznicki et al.
ANNALS OF TRANSLATIONAL MEDICINE (2014)
Role of integrated cancer nanomedicine in overcoming drug resistance
Arun K. Iyer et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?
Vivian M. Rumjanek et al.
BIOSCIENCE REPORTS (2013)
Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin
Xiaokui Huo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways
Minh Truong Do et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Autophagy Regulation and Integration with Cell Signaling
Anne Hamacher-Brady
ANTIOXIDANTS & REDOX SIGNALING (2012)
Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
Hyung Gyun Kim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin
Sarah J. Hemauer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger et al.
BRITISH JOURNAL OF CANCER (2010)
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
Issam Ben Sahra et al.
CANCER RESEARCH (2010)
Molecular Mechanisms of Biliary Excretion of Cefditoren and the Effects of Cefditoren on the Expression Levels of Hepatic Transporters
Qiang Meng et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Massimiliano Cazzaniga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Characterization of a novel metabolic strategy used by drug-resistant tumor cells
ME Harper et al.
FASEB JOURNAL (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Share Paper
